GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.

@article{Rigamonti2002GHAC,
  title={GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.},
  author={Antonello Emilio Rigamonti and Sara M Bonomo and Silvano G. Cella and Eugenio E. M{\"u}ller},
  journal={The Journal of endocrinology},
  year={2002},
  volume={174 3},
  pages={
          387-94
        }
}
GH-releasing peptides (GHRPs), a class of small synthetic peptide and non-peptide compounds, act on specific receptors at both the pituitary and the hypothalamic level to stimulate GH release in both humans and other animals. GHRPs, like corticotropin-releasing hormone (CRH), also possess acute ACTH- and cortisol-releasing activity, although the mechanisms underlying the stimulatory effect of GHRPs on the hypothalamo-pituitary-adrenal (HPA) axis are still unclear. In recent years, studies in… 

Figures and Tables from this paper

Recruiting of somatotroph cells after combined somatostatin, GHRH and growth hormone (GH) secretagogue stimulation in a study of pituitary GH reserve in prepuberal female rats.
TLDR
The results suggest that the enhanced GH release prompted by stimulation tests used to diagnose GH deficiency in prepuberal female rats does not fully reflect somatroph cell dynamics, and that not all the GH produced and stored by somatotroph cells is released into the bloodstream.
Putative somatostatin suppression potentiates adrenocorticotropin secretion driven by ghrelin and human corticotropin-releasing hormone.
TLDR
It is indicated that the peptide ensemble comprising ghrelin, CRH, and SS (inferred by l-arginine infusion) can regulate ACTH and cortisol secretion in healthy adults.
Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.
TLDR
The view that a high endogenous GHRH tone, which subsides in the recovery phase of the disease, is present in AN and, to a lesser extent, in NW, is supported, as well as in OB, which failed to evoke a plasma GH rise.
Abuse of Recombinant Human Growth Hormone: Studies in Two Different Dog Models
TLDR
In conclusion, these studies show that a single administration of rhGH can abrogate the cGH response ensuing SSIW or acute stimulation by a GHRP, and the inhibitory effect of rh GH on the c GH response to GHRH is shown.
Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone.
TLDR
It is inferred that ghrelin can activate hypothalamo-pituitary pathways that are both dependent upon and independent of somatostatinergic restraint even in the face of a strong stress-related signal.
Interaction of Kisspeptin and the Somatotropic Axis
TLDR
Present data support the concept of a central site of action for the effect of kisspeptin to stimulate GH release is due to an interaction with growth hormone-releasing hormone (GHRH) or somatostatin (SS), or an effect at the hypothalamus.
Orexigenic effects of a growth hormone secretagogue and nitric oxide in aged rats and dogs: correlation with the hypothalamic expression of some neuropeptidergic/receptorial effectors mediating food intake.
TLDR
The results obtained strengthen the proposition that, in the hypothalamus of old rats, anti-anorexigenic compensatory mechanisms are operative, aimed at maintaining a "normal" feeding pattern.
Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.
TLDR
Age, DHT concentrations, AVF, and secretagogue type influence pulsatile cortisol secretion at least in men.
Hypocortisolemic clamp unmasks jointly feedforward- and feedback-dependent control of overnight ACTH secretion.
TLDR
The combined data predict overnight amplification and coordination of hypothalamic feedforward drive onto ACTH release, which might contribute to clinical pathophysiology, such as late-day elevations of cortisol output in fasting, alcoholism, depression, or aging.
Seasonal effects of GnIH on basal and GnRH-induced goldfish somatotrope functions.
TLDR
The results indicate that gGnIH exerts complex effects on basal and GnRH-stimulated goldfish GH cell functions and can differentially affect GH release and mRNA expression in a seasonal reproductive manner.
...
1
2
...

References

SHOWING 1-10 OF 58 REFERENCES
Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
TLDR
The uniformity of the GH rebound responses to multiple cycles of SSIW may indicate that the latter activate a physiological mechanism which mimics that normally controlling GH pulse generation.
Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
TLDR
It is suggested that GHRP-6 acts via the hypothalamus to mediate the release of ACTH, and that these effects are probably mediated at least in part via therelease of endogenous CRH and are subject to regulation by circulating glucocorticoids.
Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
TLDR
The ACTH- and cortisol-releasing activity of HEX is similar to that of hCRH in normal subjects, whereas it is dramatically enhanced in patients with Cushing's disease, suggesting that it could be at least partially independent of CRH-mediated mechanisms.
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
TLDR
It is demonstrated that GHRPs, beside their well-known GH-re releasing activity, possess a remarkable ACTH-releasing activity, overlapping with that of AVP and similar to that of hCRH, two neurohormones which are known to play the major role in the control of the pituitary-adrenal axis.
Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats.
TLDR
It is investigated whether acute withdrawal of SRIF can induce GRF release by the rat hypothalamus using highly specific antisera against SRIF and rat GRF and in urethane-anaesthetized rats an acute phasic GH release was caused by SRIF antiserum despite the interference of anaesthesia with spontaneous GH secretion.
Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.
Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
TLDR
The neuroendocrine mechanism by which hexarelin and GHRP-6, two GH-releasing peptides, mediate their actions was examined and plasma GH responses were similar to those observed in the CTLas-pretreated animals.
Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency.
TLDR
It is concluded that an intact G HRH signaling system is critical for GHRPs to exert their effect on GH release, but that the GHRH system is not necessary for the effect of GHRP on PRL and ACTH secretion.
Effects of Dexamethasone and Alprazolam, a Benzodiazepine, on the Stimulatory Effect of Hexarelin, a Synthetic GHRP, on ACTH, Cortisol and GH Secretion in Humans
TLDR
The present data demonstrate that the ACTH- and cortisol-releasing effect of HEX is abolished by either dexamethasone or alprazolam, a benzodiazepine, which is even able to blunt the GH-re releasing activity of the hexapeptide.
...
1
2
3
4
5
...